MCID: ECL001
MIFTS: 54

Eclampsia malady

Categories: Rare diseases, Cardiovascular diseases

Aliases & Classifications for Eclampsia

Aliases & Descriptions for Eclampsia:

Name: Eclampsia 12 50 29 52 42 14 69
Eclampsia in Puerperium 12 69
Eclampsia, Postpartum 12
Postpartum Eclampsia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:13593
ICD10 33 O15 O15.9 O15.2
MeSH 42 D004461
NCIt 47 C87167
UMLS 69 C0013537

Summaries for Eclampsia

Disease Ontology : 12 A pre-eclampsia characterized by the presence of seizures.

MalaCards based summary : Eclampsia, also known as eclampsia in puerperium, is related to pyelonephritis and myocardial infarction, and has symptoms including seizures An important gene associated with Eclampsia is TAC3 (Tachykinin 3), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Complement and coagulation cascades. The drugs Methyldopa and Remifentanil have been mentioned in the context of this disorder. Affiliated tissues include endothelial, placenta and kidney, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 71 Eclampsia is the onset of seizures (convulsions) in a woman with pre-eclampsia. Pre-eclampsia is a... more...

Related Diseases for Eclampsia

Diseases in the Eclampsia family:

Pre-Eclampsia Severe Pre-Eclampsia

Diseases related to Eclampsia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 203)
id Related Disease Score Top Affiliating Genes
1 pyelonephritis 29.2 EDN1 F2 SERPINC1
2 myocardial infarction 28.4 ALB EDN1 F2 F5 MTHFR PGF
3 severe pre-eclampsia 12.4
4 pre-eclampsia 12.3
5 preeclampsia/eclampsia 1 12.2
6 mild pre-eclampsia 12.2
7 preeclampsia/eclampsia 5 12.1
8 preeclampsia/eclampsia 4 12.1
9 preeclampsia/eclampsia 2 11.8
10 preeclampsia/eclampsia 3 11.8
11 hellp syndrome 11.4
12 gestational diabetes 11.1
13 hypertensive encephalopathy 11.1
14 chorea gravidarum 10.8
15 endotheliitis 10.4
16 multiple familial trichoepithelioma 10.3 F5 MTHFR
17 achromatopsia 10.3 ENG FLT1 PGF
18 absence of innominate vein 10.3 F5 MTHFR
19 congenital insensitivity to pain with severe intellectual disability 10.3 F2 F5
20 lung cancer 10.3 F5 HLA-G MTHFR
21 nondystrophic myotonia 10.2 ALB F2
22 vulvitis 10.2 F2 FLT1 PGF
23 lubinsky syndrome 10.2 F2 F5 MTHFR
24 supraumbilical midabdominal raphe and facial cavernous hemangiomas 10.2 F2 F5 MTHFR
25 photosensitive epilepsy 10.2 F2 F5 MTHFR
26 houlston ironton temple syndrome 10.2 F2 F5 MTHFR
27 villous adenoma 10.2 F2 F5 MTHFR
28 aminoaciduria 10.2 F5 MTHFR
29 scn8a-related epilepsy with encephalopathy 10.2 F2 MTHFR
30 vernal conjunctivitis 10.2 ALB FLT1 MTHFR
31 citrullinemia, type ii, neonatal-onset 10.2 ALB FLT1 PGF
32 hypertrichosis 10.1 F5 MTHFR SERPINC1
33 myosclerosis, congenital 10.1 F5 MTHFR SERPINC1
34 pancreatic ductal carcinoma 10.1 F2 F5 SERPINC1
35 childhood type dermatomyositis 10.1 F2 F5 MTHFR
36 blepharochalasis 10.1 MTHFR OXT PGF
37 lymphocytic colitis 10.1 F2 F5 SERPINC1
38 stt3a-cdg and stt3b-cdg 10.1 F5 SERPINC1
39 neuroaxonal dystrophy 10.1 F2 F5 SERPINC1
40 mixed epithelial tumor of ovary 10.1 F2 MTHFR SERPINC1
41 intestinal disaccharidase deficiency 10.1 F2 F5 SERPINC1
42 pregnancy loss, recurrent 2 10.1 F2 F5 SERPINC1
43 myopia 10.1 ALB EDN1 F2
44 oguchi disease-2 10.1 F2 F5 SERPINC1
45 encephalopathy 10.1
46 hypoxia 10.1
47 central retinal artery occlusion 10.1 F2 MTHFR SERPINC1
48 freiberg's disease 10.1 ALB F2 SERPINC1
49 aids dementia complex 10.1 F2 F5 SERPINC1
50 cleft lip 10.1 F5 MTHFR SERPINC1

Graphical network of the top 20 diseases related to Eclampsia:



Diseases related to Eclampsia

Symptoms & Phenotypes for Eclampsia

UMLS symptoms related to Eclampsia:


seizures

MGI Mouse Phenotypes related to Eclampsia:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.1 EDN1 ENG F2 F5 FLT1 NOSTRIN
2 homeostasis/metabolism MP:0005376 10.03 ALB EDN1 ENG F2 F5 FLT1
3 growth/size/body region MP:0005378 10 EDN1 ENG F2 F5 FLT1 INHBB
4 digestive/alimentary MP:0005381 9.97 F2 INHBB OXT TAC3 THBD ALB
5 embryo MP:0005380 9.92 ENG F2 F5 FLT1 PGF SERPINC1
6 integument MP:0010771 9.56 F5 INHBB MTHFR OXT PGF THBD
7 mortality/aging MP:0010768 9.44 ALB EDN1 ENG F2 F5 FLT1

Drugs & Therapeutics for Eclampsia

Drugs for Eclampsia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 331)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methyldopa Approved Phase 4,Phase 2,Phase 1 555-30-6 38853
2
Remifentanil Approved Phase 4,Phase 2 132875-61-7 60815
3
Selenium Approved, Vet_approved Phase 4,Phase 2,Phase 3 7782-49-2
4
Metformin Approved Phase 4,Phase 3 657-24-9 14219 4091
5
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
6
Dalteparin Approved Phase 4,Phase 2,Phase 3 9041-08-1
7
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3 9005-49-6 772 46507594
8
Zinc Approved Phase 4,Phase 2,Phase 3 7440-66-6 32051 23994
9
Ephedrine Approved Phase 4,Phase 3 299-42-3 9294
10
Oxymetazoline Approved Phase 4 1491-59-4 4636
11
Phenylephrine Approved Phase 4 59-42-7 6041
12
Pseudoephedrine Approved Phase 4,Phase 3 90-82-4 7028
13
Labetalol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 36894-69-6 3869
14
Magnesium Sulfate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 7487-88-9 24083
15
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
16
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
17
Bupivacaine Approved, Investigational Phase 4,Phase 3 2180-92-9, 38396-39-3 2474
18
Levobupivacaine Approved Phase 4 27262-47-1 92253
19
Captopril Approved Phase 4 62571-86-2 44093
20
Clonidine Approved Phase 4,Phase 1,Phase 2 4205-90-7 2803
21
Insulin Lispro Approved Phase 4 133107-64-9
22
Acetaminophen Approved Phase 4,Phase 2,Phase 3 103-90-2 1983
23
Ibuprofen Approved Phase 4,Phase 2,Phase 3 15687-27-1 3672
24
Nifedipine Approved Phase 4,Phase 1,Phase 2,Early Phase 1 21829-25-4 4485
25
Calcium carbonate Approved Phase 4 471-34-1
26
Benzocaine Approved Phase 4,Phase 3 1994-09-7, 94-09-7 2337
27
Desogestrel Approved Phase 4 54024-22-5 40973
28
Etonogestrel Approved, Investigational Phase 4 54048-10-1 40976 6917715
29
Amlodipine Approved Phase 4 88150-42-9 2162
30
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1 59-30-3 6037
31
leucovorin Approved, Nutraceutical Phase 4,Phase 3 58-05-9 54575, 6560146 143
32
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 1,Phase 2 67-97-0 6221 10883523 5280795
33
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 1,Phase 2 50-14-6 5280793
34 tannic acid Approved, Nutraceutical Phase 4,Phase 3
35 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
36 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
37 Adrenergic Agonists Phase 4,Phase 3,Phase 2,Phase 1
38 Adrenergic alpha-2 Receptor Agonists Phase 4,Phase 2,Phase 1
39 Adrenergic alpha-Agonists Phase 4,Phase 3,Phase 2,Phase 1
40 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
41 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
42 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
43 Sympatholytics Phase 4,Phase 2,Phase 1,Early Phase 1
44 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
45 Analgesics, Opioid Phase 4,Phase 3,Phase 2
46 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1
47 Anesthetics, General Phase 4,Phase 3,Phase 2
48 Anesthetics, Intravenous Phase 4,Phase 3,Phase 2
49 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1
50 Hypnotics and Sedatives Phase 4,Phase 2

Interventional clinical trials:

(show top 50) (show all 395)
id Name Status NCT ID Phase
1 Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Unknown status NCT01361425 Phase 4
2 Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia Unknown status NCT00117546 Phase 4
3 Remifentanil for General Anesthesia in Preeclamptics Unknown status NCT00567957 Phase 4
4 Selenium Supplementation in Pregnancy Unknown status NCT01465867 Phase 4
5 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4
6 Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Completed NCT01729468 Phase 4
7 Effects of Magnesium Sulphate on Sugammadex Reversal of Rocuronium Induced Blockade in Gynaecology Patients Completed NCT01972659 Phase 4
8 Diuretics for Postpartum High Blood Pressure in Preeclampsia Completed NCT02163655 Phase 4
9 Treatment Approaches to Preeclampsia Completed NCT01030627 Phase 4
10 Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Completed NCT01352234 Phase 4
11 Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies Completed NCT01608347 Phase 4
12 Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia Completed NCT02699827 Phase 4
13 A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen Completed NCT02091401 Phase 4
14 Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia Completed NCT01408979 Phase 4
15 A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia Completed NCT00403572 Phase 4
16 Hemodynamic Measurements in Women With Serious Preeclampsia Completed NCT00199810 Phase 4
17 Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure Completed NCT01761916 Phase 4
18 Metformin Versus Insulin in Gestational Diabetes Completed NCT01240785 Phase 4
19 Phenylephrine Versus Ephedrine in Pre-eclampsia Recruiting NCT02025426 Phase 4
20 Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia Recruiting NCT03164304 Phase 4
21 The Effect of Ibuprofen on Post-partum Blood Pressure in Women With Hypertensive Disorders of Pregnancy Recruiting NCT02891174 Phase 4
22 Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features Recruiting NCT02911701 Phase 4
23 Early Vascular Adjustments During Hypertensive Pregnancy Recruiting NCT02531490 Phase 4
24 Low Dose Calcium to Prevent Preeclampsia Recruiting NCT02338687 Phase 4
25 A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Recruiting NCT02920593 Phase 4
26 Atenativ Effect on Uterine Blood Flow and Preeclampsia Recruiting NCT02278575 Phase 4
27 Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy Recruiting NCT01912677 Phase 4
28 Contraception in Women With Sickle Cell Disease Active, not recruiting NCT02594462 Phase 4
29 Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation Active, not recruiting NCT02353806 Phase 4
30 Different Schemes of Magnesium Sulfate for Preeclampsia Terminated NCT02396030 Phase 4
31 LMWH to Prevent Preeclampsia and Fetal Growth Restriction Terminated NCT00260520 Phase 4
32 Investigating the Novel Observation of Right-Left Difference in Uterine Artery Vascular Resistance in Pre-Eclampsia Unknown status NCT00848679 Phase 3
33 Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and Nicardipine Unknown status NCT00409253 Phase 3
34 Randomized Clinical Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients. Unknown status NCT02050529 Phase 2, Phase 3
35 Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia Unknown status NCT01382732 Phase 3
36 A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy Unknown status NCT02032186 Phase 3
37 Low Dose Aspirin for the Prevention of Preeclampsia Unknown status NCT01890005 Phase 3
38 PP13 and Doppler Study to Predict Preeclampsia Unknown status NCT00928213 Phase 2, Phase 3
39 Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases Unknown status NCT00872365 Phase 2, Phase 3
40 Folic Acid Dosage and Malformations Reduction Unknown status NCT01244347 Phase 3
41 New Magnesium Sulphate Protocol for Pre-eclampsia Completed NCT01846156 Phase 3
42 Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction Completed NCT00197340 Phase 3
43 Magnesium Sulfate in Pregnancy and Postpartum Completed NCT02317146 Phase 2, Phase 3
44 Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia Completed NCT01988298 Phase 2, Phase 3
45 L-Arginine in Pre-Eclampsia Completed NCT00157521 Phase 3
46 Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention Completed NCT02301780 Phase 3
47 Induction With Foley OR Misoprostol (INFORM) Study Completed NCT01801410 Phase 3
48 Calcium for Pre-Eclampsia Prevention (CPEP) Completed NCT00000534 Phase 3
49 Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol Completed NCT02086994 Phase 3
50 Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia? Completed NCT01278459 Phase 3

Search NIH Clinical Center for Eclampsia

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: eclampsia

Genetic Tests for Eclampsia

Genetic tests related to Eclampsia:

id Genetic test Affiliating Genes
1 Eclampsia 29

Anatomical Context for Eclampsia

MalaCards organs/tissues related to Eclampsia:

39
Endothelial, Placenta, Kidney, Testes, Neutrophil, Liver, Breast

Publications for Eclampsia

Articles related to Eclampsia:

(show top 50) (show all 1646)
id Title Authors Year
1
Re: Lung and cardiac ultrasound for hemodynamic monitoring of patients with severe pre-eclampsia. J. Ambrozic, G. Brzan Simenc, K. Prokselj, N. Tulz, M. Cvijic and M. Lucovnik. Ultrasound Obstet Gynecol 2017; 49: 104-109. ( 28058788 )
2017
2
Accuracy of competing risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. ( 28067011 )
2017
3
Evaluation of the predictive value of placental vascularisation indices derived from 3-Dimensional power Doppler whole placental volume scanning for prediction of pre-eclampsia: A systematic review and meta-analysis. ( 28089506 )
2017
4
Lung and cardiac ultrasound for hemodynamic monitoring of patients with severe pre-eclampsia. ( 27736042 )
2017
5
Assessment of quality of care among in-patients with postpartum haemorrhage and severe pre-eclampsia at st. Francis hospital nsambya: a criteria-based audit. ( 28086822 )
2017
6
Evaluation of MicroRNA-210 and Protein tyrosine phosphatase, non-receptor type 2 in Pre-eclampsia. ( 27746364 )
2017
7
Association between interleukin-4 polymorphisms and risk of pre-eclampsia in a population of Chinese pregnant women. ( 28387873 )
2017
8
The effects of sildenafil citrate on uterine angiogenic status and serum inflammatory markers in an L-NAME rat model of pre-eclampsia. ( 27940055 )
2017
9
Re: Pre-eclampsia: an important risk factor for asymptomatic heart failure. C. Ghossein-Doha, J. van Neer, B. Wissink, N. Breetveld, L. J. de Windt, A. P. J. van Dijk, M. J. van der Vlugt, M. C. H. Janssen, W. M. Heidema, R. R. Scholten and M. E. A. Spaanderman. Ultrasound Obstet Gynecol 2017; 49: 143-149. ( 28058791 )
2017
10
Re: Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia. R. Orabona, E. Sciatti, E. Vizzardi, I. Bonadei and A. Valcamonico. Ultrasound Obstet Gynecol 2017; 49: 116-123. ( 28058790 )
2017
11
Prospective assessment of neurodevelopment in children following a pregnancy complicated by severe pre-eclampsia. ( 27388354 )
2016
12
Serious maternal complications in relation to severe pre-eclampsia: a retrospective cohort study of the impact of hospital volume. ( 27770512 )
2016
13
Contrast extravasation through MRI precedes cerebral hemorrhage in a patient with eclampsia. ( 27885447 )
2016
14
A pre-eclampsia-associated Epstein-Barr virus antibody cross-reacts with placental GPR50. ( 27181993 )
2016
15
Diagnostic accuracy of spot urine protein-to-creatinine ratio for proteinuria and its association with adverse pregnancy outcomes in Chinese pregnant patients with pre-eclampsia. ( 27149973 )
2016
16
EP17.16: Angiogenic factors and uterine artery Doppler for prediction of pre-eclampsia in high-risk population. ( 27644456 )
2016
17
Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia. ( 26382559 )
2016
18
Helicobacter pylori infection and pre-eclampsia in a Romanian study group. ( 27612532 )
2016
19
Pre-eclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis. ( 27646865 )
2016
20
Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study. ( 26205065 )
2016
21
EP17.17: Preconceptional fat mass and hemodynamic evaluation as early predictor of pre-eclampsia risk. ( 27644709 )
2016
22
Plasma PP13 and urinary GAGs/PGs as early markers of pre-eclampsia. ( 27161490 )
2016
23
Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia. ( 26228018 )
2016
24
Optimizing treatment for the prevention of pre-eclampsia/eclampsia in Nepal: is calcium supplementation during pregnancy cost-effective? ( 28035193 )
2016
25
Cohort profile: the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC). ( 28067621 )
2016
26
Heart Disease, hypertension, gestational diabetes and pre-eclampsia/eclampsia in mothers with juvenile arthritis: A nested case-control study. ( 27111101 )
2016
27
The Expression of T-Helper Associated Transcription Factors and Cytokine Genes in Pre-Eclampsia. ( 27999241 )
2016
28
Comparison of maternal serum lipoproteins in normal pregnancy and primiparous patients with eclampsia. ( 27648061 )
2016
29
Fetal sex-specific differences in gestational age at delivery in pre-eclampsia: a meta-analysis. ( 27605586 )
2016
30
Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. ( 27094586 )
2016
31
Ibuprofen versus acetaminophen as a post-partum analgesic for women with severe pre-eclampsia: randomized clinical study. ( 27384376 )
2016
32
Toward a better understanding of the oocyte donation/pre-eclampsia connection. ( 27140289 )
2016
33
Eclampsia in India Through the Decades. ( 27651598 )
2016
34
Antenatal corticosteroid therapy for foetal maturation in women with eclampsia and severe pre-eclampsia in a rural hospital in Western Tanzania. ( 27543098 )
2016
35
OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION. ( 27643043 )
2016
36
Tumor Necrosis Factor-I+ and Interleukin-1-I^ Polymorphisms in Pre-Eclampsia. ( 27999242 )
2016
37
Predictive value of 4-, 8-, and 12-h urine protein and protein-to-creatinine ratio for detection of pre-eclampsia. ( 27113418 )
2016
38
First trimester screening for pre-eclampsia. ( 27630745 )
2016
39
Endothelial dysfunction and arterial stiffness in pre-eclampsia demonstrated by the EndoPAT method. ( 27196639 )
2016
40
Associations between pre-eclampsia and protein C and proteinA S levels among pregnant Nigerian women. ( 28092096 )
2016
41
Serum markers of pre-eclampsia identified on proteomics. ( 27279411 )
2016
42
EP17.18: Comparison of perinatal outcomes in early- and late-onset pre-eclampsia. ( 27644986 )
2016
43
Study on Neurological Consequence of Eclampsia. ( 27612881 )
2016
44
Translational studies for exercise in high-risk pregnancy: Pre-eclampsia model. ( 27159274 )
2016
45
OS 04-03 EVALUATION OF THE DIAGNOSTIC VALUE OF THE FIRST TRIMESTER MATERNAL SERUM HIGH SENSITIVE C-REACTIVE PROTEIN (HS-CRP) LEVEL FOR PREDICTION OF PRE-ECLAMPSIA. ( 27643304 )
2016
46
The Pre-Eclampsia Ontology: A Disease Ontology Representing the Domain Knowledge Specific to Pre-Eclampsia. ( 27788142 )
2016
47
EP17.15: Prediction of pre-eclampsia and IUGR by uterine artery Doppler sonography. ( 27644183 )
2016
48
Cardiac arrest during emergency cesarean section for severe pre-eclampsia and peripartum cardiomyopathy. ( 26927264 )
2016
49
Author's reply re: Microcirculation in women with severe pre-eclampsia and HELLP syndrome: a case control study. ( 27531337 )
2016
50
Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein. ( 27939474 )
2016

Variations for Eclampsia

Expression for Eclampsia

Search GEO for disease gene expression data for Eclampsia.

Pathways for Eclampsia

GO Terms for Eclampsia

Cellular components related to Eclampsia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.65 ALB EDN1 F2 F5 FLT1 INHBB
2 endoplasmic reticulum lumen GO:0005788 9.46 ALB F2 F5 SERPINC1
3 extracellular space GO:0005615 9.4 ALB EDN1 ENG F2 F5 FLT1

Biological processes related to Eclampsia according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.85 EDN1 F2 FLT1 PGF STOX1
2 cellular protein metabolic process GO:0044267 9.71 ALB F2 F5 SERPINC1
3 positive regulation of angiogenesis GO:0045766 9.69 ENG FLT1 PGF
4 blood coagulation GO:0007596 9.62 F2 F5 SERPINC1 THBD
5 positive regulation of renal sodium excretion GO:0035815 9.49 EDN1 OXT
6 negative regulation of blood coagulation GO:0030195 9.48 EDN1 THBD
7 negative regulation of fibrinolysis GO:0051918 9.43 F2 THBD
8 negative regulation of platelet activation GO:0010544 9.37 F2 THBD
9 response to transforming growth factor beta GO:0071559 9.26 EDN1 ENG
10 female pregnancy GO:0007565 9.26 OXT PGF TAC3 THBD
11 positive regulation of prostaglandin secretion GO:0032308 9.16 EDN1 OXT
12 hemostasis GO:0007599 8.92 F2 F5 SERPINC1 THBD

Molecular functions related to Eclampsia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.8 EDN1 INHBB OXT

Sources for Eclampsia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....